Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity ... able to sell copycat versions of the drugs while they were in shortage. Novo Nordisk, the ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

Wegovy and Novo Nordisk’s (NVO) Ozempic has been resolved. Semaglutide injections, which have become a popular treatment option for weight loss as well as Type 2 diabetes, have been considered to be ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

“We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming ...

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

The FDA declared the end of the shortage of Novo Nordisk’s Wegovy and Ozempic, impacting compounding pharmacies selling ...

The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration ...